Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer
Primary Purpose
Asthma
Status
Completed
Phase
Phase 2
Locations
El Salvador
Study Type
Interventional
Intervention
Human-Powered Nebulizer
Sponsored by

About this trial
This is an interventional treatment trial for Asthma focused on measuring Asthma, Nebulizers, Salbutamol, Developing Countries
Eligibility Criteria
Inclusion Criteria:
- Suffering from Mild or Moderate Asthma symptoms
- Increased respiratory rate, but not over 30 breaths per minute
- Reduced peak expiratory flow rate, but not less than 60% of normal
- Oxygen saturation levels reduced but greater than 90%
Exclusion Criteria:
- Any other respiratory condition that would interfere with nebulizer treatment
- If any other medication is being taken at the time
- Pregnant women or women who may think they might be pregnant
- Never taken salbutamol before
Sites / Locations
- Hospital Nacional San Bartolo
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Electric Nebulizer
Human-Powered Nebulizer
Arm Description
Pulmo-Aide Model 5650D
Human-Powered
Outcomes
Primary Outcome Measures
Improvement in Peak Expiratory Flow
Secondary Outcome Measures
Improvement in blood oxygenation as measured by pulse oximetry
Full Information
NCT ID
NCT01795742
First Posted
February 3, 2013
Last Updated
February 18, 2013
Sponsor
Marquette University
1. Study Identification
Unique Protocol Identification Number
NCT01795742
Brief Title
Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer
Official Title
Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer in the Treatment of Mild to Moderate Asthma in El Salvador
Study Type
Interventional
2. Study Status
Record Verification Date
February 2013
Overall Recruitment Status
Completed
Study Start Date
August 2012 (undefined)
Primary Completion Date
October 2012 (Actual)
Study Completion Date
October 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Marquette University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is an equivalence study comparing an electric nebulizer with a human-powered nebulizer--one that does not need electricity--in the treatment of mild to moderate asthma exacerbations in a regional clinic in San Salvador, El Salvador.
Detailed Description
The study design is to treat individuals suffering from mild to moderate exacerbations of asthma with nebulized salbutamol (2.5mg). Subjects will receive nebulization using either an electric nebulizer compressor or a human-powered nebulizer compressor. Improvement in peak expiratory flow will be the primary endpoint. Blood oxygenation levels as measured by pulse oximetry will be a secondary endpoint of the trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Asthma, Nebulizers, Salbutamol, Developing Countries
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
110 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Electric Nebulizer
Arm Type
Active Comparator
Arm Description
Pulmo-Aide Model 5650D
Arm Title
Human-Powered Nebulizer
Arm Type
Experimental
Arm Description
Human-Powered
Intervention Type
Device
Intervention Name(s)
Human-Powered Nebulizer
Primary Outcome Measure Information:
Title
Improvement in Peak Expiratory Flow
Time Frame
From before to after nebulizer treatment lasting approximately 30 minutes
Secondary Outcome Measure Information:
Title
Improvement in blood oxygenation as measured by pulse oximetry
Time Frame
From before to after nebulizer treatment lasting about 30 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Suffering from Mild or Moderate Asthma symptoms
Increased respiratory rate, but not over 30 breaths per minute
Reduced peak expiratory flow rate, but not less than 60% of normal
Oxygen saturation levels reduced but greater than 90%
Exclusion Criteria:
Any other respiratory condition that would interfere with nebulizer treatment
If any other medication is being taken at the time
Pregnant women or women who may think they might be pregnant
Never taken salbutamol before
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lars E Olson, Ph.D.
Organizational Affiliation
Marquette University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Nacional San Bartolo
City
Ilopango
State/Province
San Salvador
Country
El Salvador
12. IPD Sharing Statement
Citations:
PubMed Identifier
24965834
Citation
Hallberg CJ, Lysaught MT, Najarro RA, Cea Gil F, Villatoro C, Diaz de Uriarte AC, Olson LE. Treatment of asthma exacerbations with the human-powered nebuliser: a randomised parallel-group clinical trial. NPJ Prim Care Respir Med. 2014 Jun 26;24:14016. doi: 10.1038/npjpcrm.2014.16.
Results Reference
derived
Learn more about this trial
Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer
We'll reach out to this number within 24 hrs